Humanitarian Aid

The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support to national member organizations (NMOs), hemophilia treatment centres (HTCs), and healthcare practitioners (HCPs) in emerging countries.

This support comes in the form of education, training, and donated factor and non-factor replacement therapy. The objective of the program is to make it possible for people with inherited bleeding disorders to reliably access safe and consistent treatment and care, regardless of their type of bleeding disorder, gender, or location.

Since the expansion of the Humanitarian Aid Program in 2016, the WFH has become the largest distributor of donated treatment products in the world, providing tens of thousands of people living with a bleeding disorder access to care and allowing the introduction of prophylaxis and elective surgeries in dozens of countries around the world. The Program promotes identification and diagnosis, incentivizes governments to invest in bleeding disorders care, and demonstrates the positive impact of investment in treatment.

ABOUT THE WFH HUMANITARIAN AID PROGRAM

The WFH is leading the effort to change the lack of access in emerging countries by providing reliable access to safe treatment and care, regardless of a person’s type of bleeding disorder, gender or where they live. The lack of access to care and treatment in emerging countries is an urgent and important public health challenge, as the cost of products to treat inherited bleeding disorder is prohibitively expensive for the majority of those affected.

A mother smiles with her arm around her son.
0 billion

IUs of factor replacement
therapies donated

0 million

mgs of non-factor replacement
therapies donated

Since its creation in 1996, the WFH Humanitarian Aid Program has helped:

SUPPORT

0

patients
TREAT

0

bleeds
PERFORM

0

surgeries
CARE FOR

0

children
(under 10 years)

In 2025 alone, the WFH Humanitarian Aid Program has helped:

SUPPORT

0

patients
TREAT

0

bleeds
PERFORM

0

surgeries
CARE FOR

0

children
(under 10 years)

Are you part of a National Member Organization or a Hemophilia Treatment Centre and are looking to request Humanitarian Aid? Learn more here.

Formula Description Value
id 1 Patients Treated by HA Donations
id 2 Number of Acute Bleeds Treated
id 3 Total Number of Surgeries
id 4 Number of PWH on Prophylaxis under 10 Years Old
id 9 Number of PWH on Prophylaxis over 11 Years Old
id 12 Number of PWH on Prophylaxis over 11 Years Old (Emicizumab EXCLUDED)
id 15 Number of PWH on Prophylaxis over 11 Years Old (Emicizumab ONLY)
id 7 Number of PWH on Prophylaxis between 0 and 4 Years Old
id 10 Number of PWH on Prophylaxis between 0 and 4 Years Old (Emicizumab EXCLUDED)
id 13 Number of PWH on Prophylaxis between 0 and 4 Years Old (Emicizumab ONLY)
id 8 Number of PWH on Prophylaxis between 5 and 10 Years Old
id 11 Number of PWH on Prophylaxis between 5 and 10 Years Old (Emicizumab EXCLUDED)
id 14 Number of PWH on Prophylaxis between 5 and 10 Years Old (Emicizumab ONLY)
patients on prophylaxis
+ 0
Countries
0

IMPACT REPORT

Impact Report 2025

The WFH Humanitarian Aid Program also distributes treatment product through healthcare development programs such as the WFH Path to Access to Care and Treatment (PACT) Program, the WFH Twinning Program, and our country programs.

To find more information about the global impact of the WFH Humanitarian Aid Program, read the 2025 Impact Report.

View the Report  

TESTIMONIALS

Humanitarian Aid video series #Treatmentforall

RELATED VIDEOS

REQUEST HUMANITARIAN AID

In Nepal, a young child smiles shyly

The WFH Humanitarian Aid Program provides support to NMOs and HTCs all around the world. If you wish to request help, please contact us at [email protected]. To qualify for donations, your country generally needs to have a per capita use of clotting factor concentrate of less than one international unit (IU). Donations are only sent to registered HTCs or to WFH NMOs that have signed an agreement and/or MoU with the WFH Humanitarian Aid Program.

Approved NMOs or HTCs will work together with the WFH and their local authorities to obtain the necessary import licensing needed to allow the donation to be custom cleared and delivered in a timely manner. Once the relevant documentation has been prepared, the donations are packaged and shipped by RX Crossroads (U.S.A.), Gerinnungs Zentrum Rhein-Ruhr (GZRR) (Germany), or De Jong Special Services (Netherlands).

As part of the donation process, the WFH will review the utilization of donated product. This is a crucial step, as we need to understand the true need for donations and the distribution infrastructure status. Therefore, we have created an online database to facilitate reporting and processing of submitted reports.

SPONSORS

By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of our sponsors.

FOUNDING VISIONARY CONTRIBUTORS
VISIONARY CONTRIBUTORS
LEADERSHIP CONTRIBUTOR
CONTRIBUTOR
OTHER SUPPORT FROM

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.